SRPT vs TCBK · rev $1.13B vs P/E 13, rev $27.2M
Sarepta Therapeutics Inc (SRPT) versus TriCo Bancshares (TCBK) — a side-by-side from cached financials, not a winner call.
Sarepta Therapeutics Inc (SRPT) is a biotechnology company listed on US.
TriCo Bancshares (TCBK) is a banks - regional company listed on NASDAQ.
Latest reported SRPT revenue for 2026-06-30 was $1.13B. Net income was $326.1M. Revenue was up 54.9% from 2026-03-31 to 2026-06-30. SRPT currently screens at market cap $2.34B.
Latest reported TCBK revenue for 2026-06-30 was $27.2M. Net income was $67.9M. TCBK currently screens at market cap $1.64B and trailing P/E 12.9.
SRPT currently screens at market cap $2.34B. TCBK currently screens at market cap $1.64B and trailing P/E 12.9.
Not investment advice. Open the SRPT and TCBK stock pages for the full models.
Not investment advice.